Having options is helpful, particularly when it comes to patient care. Vascular access is no exception. When it comes to treating patients that present with unique situations or needs, it’s good to have options to customize treatment.
The members of Novation, the largest group purchasing organization (GPO), will continue to have options when it comes to non-tunneled CVCs, thanks to a recent contract extension with Cook Medical.
Cook’s contract with Novation began in 2012 and was recently extended through December 31, 2015. This extension allows Novation members an additional year to experience the benefits of a contract featuring Cook’s comprehensive product offering, including uncoated power-injectable polyurethane catheter options, single lumen catheters, and CVCs impregnated with Cook Spectrum technology. Proven to help prevent catheter-related bloodstream infections (CRBSI), Spectrum technology helps to save lives and reduce healthcare costs.
“We believe that Spectrum technology helps our products stand out above the rest,” Cook corporate account manager, Victoria Fritz said.
Spectrum CVCs are one of the only options on the market with a CDC 1A recommendation for preventing CRBSI, making it an important option for facilities that have been unable to meet their goals using sterile process alone.
“We strive for better patient outcomes everyday and the extension of this contract maintains a clear pathway for clinicians to access the best technology available to protect their patients from CRBSI,” Fritz said.